1. Gao GFJC. From “A” IV to “Z” IKV: attacks from emerging
and re-emerging pathogens. 2018;172(6):1157-9.
2. Pauls SJTMBoC. Masters. 2006;66:193-292.
3. Fung TS, Liu DXJArom. Human Coronavirus: Host-Pathogen
Interaction. 2019;73:529-57.
4. Tesini BJM, University of Rochester School of Medicine,
Dentistry. Coronaviruses and Acute Respiratory Syndromes
(COVID-19, MERS, and SARS). 2020.
5. Fish I, Boissinot SJI. Contrasted patterns of variation and
evolutionary convergence at the antiviral OAS1 gene in old world
primates. 2015;67(9):487-99.
6. Hovanessian AGJC, reviews gf. On the discovery of interferon-
inducible, double-stranded RNA activated enzymes: The
2′–5′ oligoadenylate synthetases and the protein kinase PKR.
2007;18(5-6):351-61.
7. Melchjorsen J, Kristiansen H, Christiansen R, Rintahaka
J, Matikainen S, Paludan SR, et al. Differential regulation of
the OASL and OAS1 genes in response to viral infections.
2009;29(4):199-208.
8. Samuel CEJCmr. Antiviral actions of interferons.
2001;14(4):778-809.
9. Lin Y, Su C, Niu J, Guo Z, Cai LJJoe. Impact of mannose-
binding lectin 2 polymorphism on the risk of hepatocellular
carcinoma: a case-control study in Chinese Han population.
2015:JE20140194.
10. Zhang H, Zhou G, Zhi L, Yang H, Zhai Y, Dong X, et al.
Association between mannose-binding lectin gene polymorphisms
and susceptibility to severe acute respiratory syndrome
coronavirus infection. 2005;192(8):1355-61.
11. He J, Feng D, de Vlas SJ, Wang H, Fontanet A, Zhang P, et
al. Association of SARS susceptibility with single nucleic acid
polymorphisms of OAS1 and MxA genes: a case-control study.
2006;6(1):106.
12. Ezekowitz RAJTJoid. Role of the mannose-binding lectin in
innate immunity. 2003;187(Supplement_2):S335-S9.
13. Ip WE, Chan KH, Law HK, Tso GH, Kong EK, Wong WH, et
al. Mannose-binding lectin in severe acute respiratory syndrome
coronavirus infection. 2005;191(10):1697-704.